Literature DB >> 14657716

Molecular evidence of anaplastic transformation in coexisting well-differentiated and anaplastic carcinomas of the thyroid.

Jennifer L Hunt1, Michael Tometsko, Virginia A LiVolsi, Patricia Swalsky, Sydney D Finkelstein, E Leon Barnes.   

Abstract

Anaplastic thyroid cancer is a rare but nearly universally fatal tumor. Epidemiologic data suggest that many anaplastic thyroid carcinomas arise from transformation of preexisting or coexisting well-differentiated thyroid carcinomas. At the molecular level, the mutations responsible for the anaplastic transformation are incompletely understood, although the mutational events are thought to involve tumor suppressor genes. To examine transformation from a well-differentiated thyroid carcinoma to anaplastic carcinoma, we studied coexisting well-differentiated (Hürthle cell and papillary carcinoma) and anaplastic tumors with a molecular genotyping panel of tumor suppressor genes associated with thyroid neoplasia. The patterns of allelic loss in our results showed that the majority of cases have a core of conserved mutations in the two morphologically distinct areas and substantial increases in mutation rates in the anaplastic components.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14657716     DOI: 10.1097/00000478-200312000-00009

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  22 in total

Review 1.  Understanding the genotype of follicular thyroid tumors.

Authors:  Jennifer Hunt
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

2.  Molecular alterations of coexisting thyroid papillary carcinoma and anaplastic carcinoma: identification of TERT mutation as an independent risk factor for transformation.

Authors:  Naoki Oishi; Tetsuo Kondo; Aya Ebina; Yukiko Sato; Junko Akaishi; Rumi Hino; Noriko Yamamoto; Kunio Mochizuki; Tadao Nakazawa; Hiroshi Yokomichi; Koichi Ito; Yuichi Ishikawa; Ryohei Katoh
Journal:  Mod Pathol       Date:  2017-07-21       Impact factor: 7.842

3.  Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma.

Authors:  Sarika N Rao; Mark Zafereo; Ramona Dadu; Naifa L Busaidy; Kenneth Hess; Gilbert J Cote; Michelle D Williams; William N William; Vlad Sandulache; Neil Gross; G Brandon Gunn; Charles Lu; Renata Ferrarotto; Stephen Y Lai; Maria E Cabanillas
Journal:  Thyroid       Date:  2017-02-16       Impact factor: 6.568

4.  Coexisting well-differentiated and anaplastic thyroid carcinoma in the same primary resection specimen: immunophenotypic and genetic comparison of the two components in a consecutive series of 13 cases and a review of the literature.

Authors:  Moira Ragazzi; Federica Torricelli; Benedetta Donati; Alessia Ciarrocchi; Dario de Biase; Giovanni Tallini; Eleonora Zanetti; Alessandra Bisagni; Elisabetta Kuhn; Davide Giordano; Andrea Frasoldati; Simonetta Piana
Journal:  Virchows Arch       Date:  2020-07-18       Impact factor: 4.064

Review 5.  Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas.

Authors:  Yuri E Nikiforov
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

Review 6.  Management of anaplastic thyroid cancer.

Authors:  Xavier M Keutgen; Samira M Sadowski; Electron Kebebew
Journal:  Gland Surg       Date:  2015-02

Review 7.  Anaplastic thyroid carcinoma: an overview.

Authors:  Wendy R Cornett; Anand K Sharma; Terry A Day; Mary S Richardson; Rana S Hoda; Jon A van Heerden; Jyotika K Fernandes
Journal:  Curr Oncol Rep       Date:  2007-03       Impact factor: 5.075

Review 8.  Surgical options in undifferentiated thyroid carcinoma.

Authors:  Brian Hung-Hin Lang; Chung-Yau Lo
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

Review 9.  Controversies in thyroid pathology: the diagnosis of follicular neoplasms.

Authors:  Stefano Serra; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

10.  PTEN and TP53 Mutations in Oncocytic Follicular Carcinoma.

Authors:  Shuanzeng Wei; Virginia A LiVolsi; Kathleen T Montone; Jennifer J D Morrissette; Zubair W Baloch
Journal:  Endocr Pathol       Date:  2015-12       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.